Point72 Asia (Singapore)’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$62.1K	Buy	43,447 +43,446	+4,344,600%	+$62.1K	0.01%	553
2025 Q1	$2	Buy	+1	New	+$2	﹤0.01%	830
2024 Q1	–	Sell	-3,928	Closed	-$22.2K	–	1072
2023 Q4	$22.2K	Buy	+3,928	New	+$22.2K	0.01%	444